CRM1-dependent function of a cis-acting RNA export element.
about
Foamy virus nuclear RNA export is distinct from that of other retrovirusesThe hepatitis B virus PRE contains a splicing regulatory element.A Hepadnavirus Regulatory Element Enhances Expression of a Type 2 Bovine Viral Diarrhea Virus E2 Protein from a Bovine Herpesvirus 1 VectorWoodchuck post-transcriptional element induces nuclear export of myotonic dystrophy 3' untranslated region transcripts.Diverse activities of viral cis-acting RNA regulatory elements revealed using multicolor, long-term, single-cell imagingDetailed mapping of the nuclear export signal in the Rous sarcoma virus Gag proteinHijacking of host calreticulin is required for the white spot syndrome virus replication cycle.Nuclear export of human hepatitis B virus core protein and pregenomic RNA depends on the cellular NXF1-p15 machinery.HIV-1 Nef-associated Factor 1 Enhances Viral Production by Interacting with CRM1 to Promote Nuclear Export of Unspliced HIV-1 gag mRNA.Adenoviral and adeno-associated viral vectors-mediated neuronal gene transfer to cardiovascular control regions of the rat brainEnhancing Transgene Expression from Recombinant AAV8 Vectors in Different Tissues Using Woodchuck Hepatitis Virus Post-Transcriptional Regulatory ElementRas-activated RSK1 phosphorylates EBP50 to regulate its nuclear localization and promote cell proliferation.Functional domain structure of human T-cell leukemia virus type 2 rex.Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias.Posttranscriptional regulatory elements enhance antigen expression and DNA vaccine efficacy.Production of pigs expressing a transgene under the control of a tetracycline-inducible system.Murine leukemia virus uses NXF1 for nuclear export of spliced and unspliced viral transcripts.Over-expression of secreted proteins from mammalian cell lines.Murine leukemia virus uses TREX components for efficient nuclear export of unspliced viral transcripts.Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS.Improved microRNA suppression by WPRE-linked tough decoy microRNA sponges.Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors.Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression.Self-inactivating retroviral vectors with improved RNA processing.Titers of lentiviral vectors encoding shRNAs and miRNAs are reduced by different mechanisms that require distinct repair strategies.Increased in vitro and in vivo transgene expression levels mediated through cis-acting elements.A Kaposi's sarcoma virus RNA element that increases the nuclear abundance of intronless transcripts.B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element.Lentiviral-mediated gene transfer – a patent review
P2860
Q24629599-C7CED10A-1384-498D-A48C-3EFBC7702260Q25255938-1AA9DA9A-939C-4AD1-9351-53EED4F7555DQ27477710-ED355F98-B38D-4801-95E1-C58BFAAE12C0Q30446658-7C3A4E01-BE11-4885-8743-CA0CD5354FEEQ30841153-490FDED1-29D8-4BDF-9138-B0B0FBDBE881Q33883903-9E7A84D8-AAB4-4A09-A511-91FF1F60FB5CQ33900228-6864A184-9E4A-4AE6-B3BA-E0BA6FCC7C70Q34433939-03C0B194-B953-41A0-9A6C-ED3893A2DDEBQ36744542-5F90B384-F8D0-4D9D-B9DE-B2D51C0868DFQ36746855-5C780CF3-F959-44AE-8786-A809E6AF9DE0Q36792325-5060B06E-13B0-4C71-B874-7DD4E9159904Q36962945-788E4229-F81A-41DE-9D0D-5C604FA00E93Q37059755-81B62B15-838E-4368-8CA4-EC9699C3D180Q37263168-04A7594F-86E0-4196-AA70-EE806100ED68Q37284470-6D619634-EFB0-4BBC-A127-5BDA01FF216DQ37484404-B9C84FF4-BD0A-4DA8-8E90-43DD0B201488Q37713848-74D29F20-5541-4A5F-88AB-24911FFD8738Q37734441-4BE7BC8B-0B69-4900-925A-77096DD86B50Q38562339-360FCBB6-3C0B-4E60-A182-0503D90FB6D8Q39877036-8D2FDCF3-191D-49D4-BEF6-64D4AD70C34EQ40208488-7E6A96A5-3F43-4A45-AF7A-DBF88099DDC8Q40269711-E9677955-A47D-408F-85A8-8FE1B67D8186Q40365103-2D498503-201C-4F89-A404-EDF275DB7435Q40515056-A0383736-7E66-4C93-9FFA-471DEA3B4F5AQ41068705-2FB5050C-8333-4B1B-B9CC-5CFB8436EF27Q42614928-BF05E3D7-C0FA-4843-9CB4-675FF8081D46Q42844909-CC07BE24-EEC1-479D-AF24-E193AB9EF574Q44296349-6D4A3D3B-4178-4D10-9BC3-AFD96A16028AQ56787021-16F9313A-6B90-4AE6-AFAA-3D114B02225E
P2860
CRM1-dependent function of a cis-acting RNA export element.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
CRM1-dependent function of a cis-acting RNA export element.
@ast
CRM1-dependent function of a cis-acting RNA export element.
@en
CRM1-dependent function of a cis-acting RNA export element.
@nl
type
label
CRM1-dependent function of a cis-acting RNA export element.
@ast
CRM1-dependent function of a cis-acting RNA export element.
@en
CRM1-dependent function of a cis-acting RNA export element.
@nl
prefLabel
CRM1-dependent function of a cis-acting RNA export element.
@ast
CRM1-dependent function of a cis-acting RNA export element.
@en
CRM1-dependent function of a cis-acting RNA export element.
@nl
P2093
P2860
P1476
CRM1-dependent function of a cis-acting RNA export element.
@en
P2093
Ileana Popa
John E Donello
Matthew E Harris
Thomas J Hope
P2860
P304
P356
10.1128/MCB.22.7.2057-2067.2002
P407
P577
2002-04-01T00:00:00Z